Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy.

Cappuccini F, Pollock E, Stribbling S, Hill AVS, Redchenko I.

Oncotarget. 2017 Jul 18;8(29):47474-47489. doi: 10.18632/oncotarget.17666.

2.

Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs.

de Leve S, Wirsdörfer F, Cappuccini F, Schütze A, Meyer AV, Röck K, Thompson LF, Fischer JW, Stuschke M, Jendrossek V.

FASEB J. 2017 Jul;31(7):2869-2880. doi: 10.1096/fj.201601228R. Epub 2017 Mar 21.

3.

Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.

Cappuccini F, Stribbling S, Pollock E, Hill AV, Redchenko I.

Cancer Immunol Immunother. 2016 Jun;65(6):701-13. doi: 10.1007/s00262-016-1831-8. Epub 2016 Apr 6.

4.

Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis.

Wirsdörfer F, de Leve S, Cappuccini F, Eldh T, Meyer AV, Gau E, Thompson LF, Chen NY, Karmouty-Quintana H, Fischer U, Kasper M, Klein D, Ritchey JW, Blackburn MR, Westendorf AM, Stuschke M, Jendrossek V.

Cancer Res. 2016 May 15;76(10):3045-56. doi: 10.1158/0008-5472.CAN-15-2310. Epub 2016 Feb 26.

5.

Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells.

Wirsdörfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, Lüdemann L, Stuschke M, Jendrossek V.

Radiat Oncol. 2014 Apr 25;9:98. doi: 10.1186/1748-717X-9-98.

6.

The membrane-targeted alkylphosphocholine erufosine interferes with survival signals from the extracellular matrix.

Chometon G, Cappuccini F, Raducanu A, Aumailley M, Jendrossek V.

Anticancer Agents Med Chem. 2014 May;14(4):578-91.

PMID:
24628265
7.

New insights into the molecular pathology of radiation-induced pneumopathy.

Cappuccini F, Eldh T, Bruder D, Gereke M, Jastrow H, Schulze-Osthoff K, Fischer U, Köhler D, Stuschke M, Jendrossek V.

Radiother Oncol. 2011 Oct;101(1):86-92. doi: 10.1016/j.radonc.2011.05.064. Epub 2011 Jun 29.

PMID:
21722981
8.

Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.

Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, Mongoue-Tchokote S, Dim D, Andrews C, Beck A, Tarumi Y, Djilas J, Cappuccini F, Caballero O, Huang J, Levy S, Tsiamouri A, Cain J, Bagby GC, Strausberg RL, Simpson AJ, Odunsi KO.

Transl Oncol. 2009 Dec;2(4):341-9.

9.

Molecular characterization of bovine rotavirus strains circulating in northern Italy, 2003-2005.

Monini M, Cappuccini F, Battista P, Falcone E, Lavazza A, Ruggeri FM.

Vet Microbiol. 2008 Jun 22;129(3-4):384-9. doi: 10.1016/j.vetmic.2007.11.036. Epub 2007 Dec 5.

PMID:
18191347
10.

Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.

Pejovic T, Yates JE, Liu HY, Hays LE, Akkari Y, Torimaru Y, Keeble W, Rathbun RK, Rodgers WH, Bale AE, Ameziane N, Zwaan CM, Errami A, Thuillier P, Cappuccini F, Olson SB, Cain JM, Bagby GC Jr.

Cancer Res. 2006 Sep 15;66(18):9017-25.

11.

Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group.

Calkins A, Stehman FB, Bundy B, Benda JA, Mannel RS, Seago P, Cappuccini F, Alvarez RD, Monk BJ, Maiman M.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):660-3.

PMID:
16681743
12.

Chemoradiation: A new approach for the treatment of cervical cancer.

Loizzi V, Cormio G, Loverro G, Selvaggi L, Disaia PJ, Cappuccini F.

Int J Gynecol Cancer. 2003 Sep-Oct;13(5):580-6. Review.

PMID:
14675339
13.

Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy.

Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML.

Am J Obstet Gynecol. 2003 Nov;189(5):1301-7.

PMID:
14634558
14.

An unusual presentation of struma ovarii mimicking a malignant process.

Loizzi V, Cappuccini F, Berman ML.

Obstet Gynecol. 2002 Nov;100(5 Pt 2):1111-2.

PMID:
12423825
15.

Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy.

Tewari KS, Cappuccini F, Puthawala AA, Kuo JV, Burger RA, Monk BJ, Manetta A, Berman ML, Disaia PJ, Nisar AM.

Cancer. 2001 Feb 15;91(4):758-70.

PMID:
11241244
16.

Obstetric emergencies precipitated by malignant brain tumors.

Tewari KS, Cappuccini F, Asrat T, Flamm BL, Carpenter SE, Disaia PJ, Quilligan EJ.

Am J Obstet Gynecol. 2000 May;182(5):1215-21.

17.

Malignant germ cell tumors of the ovary.

Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF.

Obstet Gynecol. 2000 Jan;95(1):128-33.

PMID:
10636515
18.

Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma.

Tewari K, Cappuccini F, Brewster WR, DiSaia PJ, Berman ML, Manetta A, Puthawala A, Nisar Syed AM, Kohler MF.

Gynecol Oncol. 1999 Sep;74(3):416-22. Review.

19.

Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer.

Tewari K, Cappuccini F, Syed AM, Puthawala A, DiSaia PJ, Berman ML, Manetta A, Monk BJ.

Am J Obstet Gynecol. 1999 Jul;181(1):91-8.

20.

Relapse of acute lymphoblastic leukemia in pregnancy: survival following chemoirradiation and autologous transfer of interleukin-2-activated stem cells.

Tewari K, Cappuccini F, Rosen RB, Rosenthal J, Asrat T, Kohler MF.

Gynecol Oncol. 1999 Jul;74(1):143-6. Review.

21.

Pregnancy in a Jehovah's witness with cervical cancer and anemia.

Tewari K, Cappuccini F, Balderston KD, Rose GS, Porto M, Berman ML.

Gynecol Oncol. 1998 Nov;71(2):330-2.

22.

Aggressive clinical behavior of a rare uterine sarcoma.

Cappuccini F, Tewari K, Fuller PN, Pindur A, DiSaia PJ.

Gynecol Oncol. 1998 Jul;70(1):147-51.

24.

Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy.

Tewari K, Brewer C, Cappuccini F, Macri C, Rogers LW, Berman ML.

Gynecol Oncol. 1997 Sep;66(3):531-4.

PMID:
9299272
25.
26.
27.

Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice.

Cappuccini F, Lucci JA 3rd, Dett CA, Gatanaga M, Ininns EK, Gatanaga T, Yamamoto RS, Manetta A, DiSaia PJ, Granger GA.

Gynecol Oncol. 1992 Aug;46(2):163-9.

28.

Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients.

Lucci JA 3rd, Manetta A, Cappuccini F, Ininns EK, Dett CA, DiSaia P, Yamamoto RS, Berman ML, Soopikian J, Granger GA.

Gynecol Oncol. 1992 May;45(2):129-35.

29.

Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro.

Ininns EK, Gatanaga M, Cappuccini F, Dett CA, Yamamoto RS, Granger GA, Gatanaga T.

Endocrinology. 1992 Apr;130(4):1852-6.

PMID:
1312427
30.

The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro.

Gatanaga T, Hwang CD, Gatanaga M, Cappuccini F, Yamamoto RS, Granger GA.

Cell Immunol. 1991 Nov;138(1):1-10.

31.

Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.

Cappuccini F, Yamamoto RS, DiSaia PJ, Grosen EA, Gatanaga M, Lucci JA, Ininns EK, Gatanaga T, Granger GA.

Lymphokine Cytokine Res. 1991 Jun;10(3):225-9.

PMID:
1653048
32.

Treatment of hirsutism by an association of oral cyproterone acetate and transdermal 17 beta-estradiol.

Jasonni VM, Bulletti C, Naldi S, Di Cosmo E, Cappuccini F, Flamigni C.

Fertil Steril. 1991 Apr;55(4):742-5.

PMID:
1826278
34.

Basement membrane in human endometrium: possible role of proteolytic enzymes in developing hyperplasia and carcinoma.

Bulletti C, Jasonni VM, Polli V, Cappuccini F, Galassi A, Flamigni C.

Ann N Y Acad Sci. 1991;622:376-82.

PMID:
1648321
35.

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.

Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA 3rd, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA.

Proc Natl Acad Sci U S A. 1990 Nov;87(22):8781-4.

36.

Evaluation of fractional distribution of estradiol and estrone by centrifugal ultrafiltration-dialysis.

Ciotti PM, Jasonni VM, Bulletti C, Cappuccini F, Bolelli G.

Steroids. 1988 Oct;52(4):425-6. No abstract available.

PMID:
3250045
37.

Increased extraction of estrogens in human endometrial hyperplasia and carcinoma.

Bulletti C, Jasonni VM, Tabanelli S, Ciotti P, Cappuccini F, Borini A, Flamigni C.

Cancer Detect Prev. 1988;13(2):123-30.

PMID:
3242821

Supplemental Content

Loading ...
Support Center